Omnicell, Inc. NASDAQ:OMCL

Omnicell stock price today

$31.95
-12.11
-27.49%
Financial Health
0
1
2
3
4
5
6
7
8
9

Omnicell stock price monthly change

+65.95%
month

Omnicell stock price quarterly change

+65.95%
quarter

Omnicell stock price yearly change

+14.89%
year

Omnicell key metrics

Market Cap
2.05B
Enterprise value
2.98B
P/E
503.42
EV/Sales
2.30
EV/EBITDA
30.90
Price/Sales
2.08
Price/Book
2.38
PEG ratio
-5.42
EPS
-0.46
Revenue
1.10B
EBITDA
135.76M
Income
-21.04M
Revenue Q/Q
-15.30%
Revenue Y/Y
-13.02%
Profit margin
0.44%
Oper. margin
-0.18%
Gross margin
45.45%
EBIT margin
-0.18%
EBITDA margin
12.31%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Omnicell stock price history

Omnicell stock forecast

Omnicell financial statements

Average Price Target
Last Year

$52.67

Potential upside: 64.84%

Based on estimate of 2 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Omnicell, Inc. (NASDAQ:OMCL): Profit margin
Jun 2023 298.97M 3.45M 1.15%
Sep 2023 298.66M 5.55M 1.86%
Dec 2023 258.84M -14.37M -5.55%
Mar 2024 246.15M -15.67M -6.37%
Omnicell, Inc. (NASDAQ:OMCL): Earnings per share (EPS)
2024-05-02 -0.08 0.33
Omnicell, Inc. (NASDAQ:OMCL): Debt to assets
Jun 2023 2193872000 1.03B 46.96%
Sep 2023 2221575000 1.03B 46.55%
Dec 2023 2226878000 1.03B 46.61%
Mar 2024 2283755000 1.09B 47.95%
Omnicell, Inc. (NASDAQ:OMCL): Cash Flow
Jun 2023 72.90M -14.81M 3.60M
Sep 2023 57.00M -14.18M 2.82M
Dec 2023 38.41M -12.37M 13.13M
Mar 2024 49.95M -12.34M 11.92M

Omnicell alternative data

Omnicell, Inc. (NASDAQ:OMCL): Employee count
Aug 2023 3,830
Sep 2023 3,780
Oct 2023 3,780
Nov 2023 3,780
Dec 2023 3,890
Jan 2024 3,890
Feb 2024 3,890
Mar 2024 3,650
Apr 2024 3,650
May 2024 3,650
Jun 2024 3,590
Jul 2024 3,590

Omnicell other data

61.97% -36.64%
of OMCL is owned by hedge funds
28.43M -16.74M
shares is hold by hedge funds

Omnicell, Inc. (NASDAQ:OMCL): Insider trades (number of shares)
Period Buy Sel
Dec 2024 0 12000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
PARRISH MARK W director
Common Stock 12,000 $47.3 $567,636
Sale
MELLON CHRISTINE MARIE officer: EVP, EXECUTIVE ADVISOR
Common Stock 7,951 $73.14 $581,568
Purchase
LIPPS RANDALL A director, officer: CHAIRMAN, PR..
Common Stock 4,000 $73.76 $295,040
Option
BAUER JOANNE B director
Stock Option NQ (Right to Buy) 19,329 $25.53 $493,469
Sale
BAUER JOANNE B director
Common Stock 3,318 $55.04 $182,616
Sale
BAUER JOANNE B director
Common Stock 9,797 $53.97 $528,715
Option
BAUER JOANNE B director
Common Stock 19,329 $25.53 $493,469
Option
PARRISH MARK W director
Stock Option NQ (Right to Buy) 3,000 $14.87 $44,610
Option
PARRISH MARK W director
Common Stock 3,000 $14.87 $44,610
Sale
SEIDELMANN SCOTT PETER officer: EVP, CHI.. Common Stock 945 $48.28 $45,625
Patent
Application
Filling date: 6 May 2022 Issue date: 18 Aug 2022
Grant
Filling date: 8 Apr 2020 Issue date: 2 Aug 2022
Application
Filling date: 24 Mar 2022 Issue date: 7 Jul 2022
Grant
Filling date: 31 Mar 2020 Issue date: 14 Jun 2022
Grant
Filling date: 30 Nov 2017 Issue date: 17 May 2022
Grant
Filling date: 29 Jun 2020 Issue date: 10 May 2022
Grant
Filling date: 29 Jan 2020 Issue date: 26 Apr 2022
Application
Filling date: 17 Nov 2021 Issue date: 10 Mar 2022
Application
Filling date: 28 Aug 2020 Issue date: 3 Mar 2022
Application
Filling date: 28 Aug 2020 Issue date: 3 Mar 2022
Thursday, 19 December 2024
zacks.com
Wednesday, 18 December 2024
zacks.com
zacks.com
Thursday, 12 December 2024
zacks.com
zacks.com
zacks.com
zacks.com
Monday, 9 December 2024
businesswire.com
Wednesday, 4 December 2024
zacks.com
Friday, 29 November 2024
zacks.com
Friday, 22 November 2024
businesswire.com
Thursday, 21 November 2024
zacks.com
Wednesday, 20 November 2024
businesswire.com
Monday, 18 November 2024
businesswire.com
zacks.com
Wednesday, 6 November 2024
zacks.com
Friday, 1 November 2024
seekingalpha.com
Thursday, 31 October 2024
zacks.com
zacks.com
Wednesday, 30 October 2024
seekingalpha.com
zacks.com
businesswire.com
Tuesday, 29 October 2024
zacks.com
Monday, 28 October 2024
zacks.com
Friday, 11 October 2024
etftrends.com
Monday, 7 October 2024
businesswire.com
Friday, 4 October 2024
zacks.com
zacks.com
zacks.com
Wednesday, 25 September 2024
businesswire.com
  • What's the price of Omnicell stock today?

    One share of Omnicell stock can currently be purchased for approximately $31.95.

  • When is Omnicell's next earnings date?

    Unfortunately, Omnicell's (OMCL) next earnings date is currently unknown.

  • Does Omnicell pay dividends?

    No, Omnicell does not pay dividends.

  • How much money does Omnicell make?

    Omnicell has a market capitalization of 2.05B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.48% to 1.15B US dollars. Omnicell made a loss 20.37M US dollars in net income (profit) last year or $0.33 on an earnings per share basis.

  • What is Omnicell's stock symbol?

    Omnicell, Inc. is traded on the NASDAQ under the ticker symbol "OMCL".

  • What is Omnicell's primary industry?

    Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.

  • How do i buy shares of Omnicell?

    Shares of Omnicell can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Omnicell have?

    As Jul 2024, Omnicell employs 3,590 workers, which is 2% less then previous quarter.

  • When Omnicell went public?

    Omnicell, Inc. is publicly traded company for more then 24 years since IPO on 9 Aug 2001.

  • What is Omnicell's official website?

    The official website for Omnicell is omnicell.com.

  • Where are Omnicell's headquarters?

    Omnicell is headquartered at 590 East Middlefield Road, Mountain View, CA.

  • How can i contact Omnicell?

    Omnicell's mailing address is 590 East Middlefield Road, Mountain View, CA and company can be reached via phone at +65 02516100.

  • What is Omnicell stock forecast & price target?

    Based on 2 Wall Street analysts` predicted price targets for Omnicell in the last 12 months, the avarage price target is $52.67. The average price target represents a 64.84% change from the last price of $31.95.

Omnicell company profile:

Omnicell, Inc.

omnicell.com
Exchange:

NASDAQ

Full time employees:

3,660

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

590 East Middlefield Road
Mountain View, CA 94043

CIK: 0000926326
ISIN: US68213N1090
CUSIP: 68213N109